No appeal will be filed by WADA in the Iga Świątek case

The World Anti-Doping Agency (WADA) has confirmed that after a thorough review, it will not appeal the case of Polish tennis player Iga Świątek to the Court of Arbitration for Sport (CAS). Świątek tested positive for trimetazidine (TMZ), a banned substance, in August 2024.

On 28 November, the International Tennis Integrity Agency (ITIA), the independent body responsible for anti-doping in tennis, announced that Świątek had accepted a one-month ban after it was determined that her positive test for TMZ was due to a contaminated melatonin product. This product, which is regulated as medication in Poland, was purchased from a reputable pharmacy.

WADA has reviewed the ITIA’s decision, which was received on 29 November. Its scientific experts have confirmed that the explanation of contamination by melatonin, accepted by the ITIA, is credible, and there are no scientific reasons to challenge it at CAS.

Additionally, WADA sought advice from external legal experts, who agreed that the contamination explanation was well-supported, the ITIA’s decision followed the World Anti-Doping Code, and there was no reasonable grounds for an appeal to CAS.

WADA
Click HERE to learn more

Leave a reply